Evaluation of a New Malaria Control Strategy Amongst Gold Miners Working Illegally in French Guiana (Malakit) (MALAKIT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03695770 |
|
Recruitment Status :
Completed
First Posted : October 4, 2018
Last Update Posted : May 20, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Illegal gold miners in French Guiana, a French overseas territory ('département') located in Amazonia, often carry malaria parasites (up to 46.8%). While the Guiana Shield Region aims at malaria elimination, the high prevalence of Plasmodiumin this hard-to-reach population in conjunction with frequent incorrect use of artemisinin-based anti-malarials could favor the emergence of resistant parasites. Due to geographical and regulatory issues in French Guiana, usual malaria control strategies cannot be implemented in this particular context.Therefore, new strategies targeting this specific population in the forest are required.
Numerous discussions among health institutions and scientific partners from French Guiana, Brazil and Suriname have led to an innovative project based on the distribution of kits for self-diagnosis and self-treatment of Plasmodium infections. The kit-distribution will be implemented at "resting sites", which are areas across the border of French Guiana regularly frequented by gold miners. The main objective is to increase the appropriate use and complete malaria treatment after a positive malaria diagnosis with a rapid test, which will be evaluated with before-and-after cross-sectional studies. Monitoring indicators will be collected from health mediators at the time of kit distribution and during subsequent visits, and from illegal gold miners themselves, through a smartphone application. The project funding is multisource, including Ministries of Health of the three countries, WHO/PAHO, and the European Union.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Malaria Public Health | Other: kit for self-diagnosis and self-treatment | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 3733 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | before/after study design |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Evaluation of a New Malaria Control Strategy Amongst Gold Miners Working Illegally in French Guiana (Malakit) |
| Actual Study Start Date : | April 16, 2018 |
| Actual Primary Completion Date : | March 30, 2020 |
| Actual Study Completion Date : | March 30, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: target population
All the target population should be included in the experimental arm
|
Other: kit for self-diagnosis and self-treatment
distribution of kits for malaria self-diagnosis and self-treatment after a training by health facilitators |
- KAP Questionnaire [ Time Frame: 12 months ]change the part of illegal gold miners in French Guiana who take a correct antimalarial treatment (with artemisinin-combined therapy) with a good adherence and after a positive rapid diagnostic test.
- malaria prevalence [ Time Frame: 12 months ]change PCR-Plasmodium prevalence amongst gold miners working illegally in French Guiana
- KAP questionnaire [ Time Frame: 12 months ]change the use of protection measures against mosquitoes
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 15 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- over 15 years-old
- working or accompanying someone working in illegal gold mining in French Guiana
- agreing to take part of the study
- to have parents authorization if age between 15 and 17 ;
- capable of performing a self-RDT during the training (validation by the facilitator);
Exclusion Criteria:
- refusing to participate in the study ;
- under 15 years old ;
- no parents authorization ;
- weighing less than 35 kg ;
- who has not been able to perform a self-RDT during the training (invalidation by the facilitator).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03695770
| Brazil | |
| Fondation Oswaldo Cruz | |
| Rio De Janeiro, Brazil | |
| Suriname | |
| Foundation for Scientific Research Suriname (SWOS) | |
| Paramaribo, Suriname | |
| Responsible Party: | Centre Hospitalier de Cayenne |
| ClinicalTrials.gov Identifier: | NCT03695770 |
| Other Study ID Numbers: |
MALAKIT |
| First Posted: | October 4, 2018 Key Record Dates |
| Last Update Posted: | May 20, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Malaria Protozoan Infections Parasitic Diseases Infections Vector Borne Diseases |

